Product search
Sort by
Search results
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.
HEMOCLOT Protein C
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
TRAP-6
Thrombin receptor activator peptide-6 (TRAP-6) reagent can be used as an alternative to thrombin as a platelet activator in order to study platelet dysfunction or normal platelet activity in human platelet rich plasma or whole blood.
CRYOcheck Factor VIII Deficient Plasma with VWF, frozen
Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.
CRYOcheck Factor VIII Deficient Plasma with VWF, frozen
Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.
5-ELISA ADAMTS-13 Antigen
Measurement of ADAMTS-13 antigen in human plasma by one-step method or two-step method.
LIAPHEN™ Protein C
Quantitative determination of protein C antigen in human citrated plasma.
Factor IX deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor IX deficient plasma.
BIOPHEN Factor VIII (bovine reagent R1)
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A) Follow-up of FVIII recovery in treated patients (exceptemicizumab) Factor VIII inhibitor assay in presence oemicizumab Measurement of high FVIII concentrations
CRYOcheck Chromogenic Factor IX
This chromogenic assay is intended to be used as an aid in the management of hemophilia B in individuals aged two years or older. With a limit of quantification of 0.7% FIX activity and a test range of 0–200% FIX CRYO check Chromogenic Factor IX provides unsurpassed assurance in results, especially in cases of patients with severe hemophilia B.